Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:704-711
Published online before print January 14, 2008, doi: 10.1161/HYPERTENSIONAHA.107.098459
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/3/704    most recent
HYPERTENSIONAHA.107.098459v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, E. R.
Right arrow Articles by Meszaros, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, E. R.
Right arrow Articles by Meszaros, J. G.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Remodeling
Right arrow ACE/Angiotension receptors
Right arrow Receptor pharmacology

(Hypertension. 2008;51:704.)
© 2008 American Heart Association, Inc.


Original Articles

Angiotensin II-Induced Extracellular Signal-Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase C{delta} and Intracellular Calcium in Adult Rat Cardiac Fibroblasts

Erik R. Olson; Patricia E. Shamhart; Jennifer E. Naugle; J. Gary Meszaros

From the Department of Physiology and Pharmacology, Northeastern Ohio Universities College of Medicine, Rootstown; and the Graduate Program, School of Biomedical Sciences, Kent State University, Kent, Ohio.

Correspondence to J. Gary Meszaros, Northeastern Ohio Universities College of Medicine, Department of Physiology and Pharmacology, 4209 State Rt 44, Rootstown, OH 44272-0095. E-mail jgmeszar{at}neoucom.edu

Angiotensin II (Ang II)-induced proliferation of cardiac fibroblasts is a major contributing factor to the pathogenesis of cardiac fibrosis. Ang II activates extracellular signal-regulated kinase (ERK) 1/2 to induce cardiac fibroblast proliferation, but the signaling pathways leading to ERK 1/2 activation have not been elucidated in these cells. The goal of the current study was to identify the intracellular mediators of Ang II-induced ERK 1/2 activation in adult rat cardiac fibroblasts. We determined that 100 nmol/L of Ang II-induced ERK 1/2 phosphorylation is inhibited by simultaneous chelation of cytosolic calcium and downregulation of protein kinase C (PKC) by phorbol ester or by the specific PKC{delta} inhibitor rottlerin, as well as PKC{delta} small interfering RNA, but not by inhibition of 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate, phorbol ester, rottlerin, or PKC{delta} small interfering RNA alone. We also found that Ang II does not transactivate the epidermal growth factor receptor in adult cardiac fibroblasts, because pretreatment with 1 µmol/L of AG 1478 did not significantly inhibit [3H]-thymidine incorporation or ERK 1/2 activation. In addition, immunoprecipitation of the epidermal growth factor receptor demonstrated no significant Ang II-induced phosphorylation of tyrosine residues. Inhibition of phosphatidylinositide 3-kinase, PKC{zeta}, and src tyrosine kinase had no effect on Ang II-induced ERK 1/2 activation. Collectively, these data demonstrate that Ang II does not transactivate the epidermal growth factor receptor in adult rat cardiac fibroblasts to activate ERK 1/2, a common pathway described in vascular smooth muscle and other cell types, but rather occurs via activation of distinct parallel signaling pathways mechanistically controlled by intracellular Ca2+ and PKC{delta}.


Key Words: cellular proliferation • mitogen-activated protein kinase • transactivation • heart failure • fibrosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Shamhart, D. J. Luther, B. R. Hodson, J. C. Koshy, V. Ohanyan, and J. G. Meszaros
Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1147 - E1153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Villarreal, S. A. Epperson, I. Ramirez-Sanchez, K. G. Yamazaki, and L. L. Brunton
Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1178 - C1184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ying, P. Yue, X. Xu, M. Zhong, Q. Sun, M. Mikolaj, A. Wang, R. D. Brook, L. C. Chen, and S. Rajagopalan
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1540 - H1550.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. S. Palaniyandi, L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen
Protein kinase C in heart failure: a therapeutic target?
Cardiovasc Res, May 1, 2009; 82(2): 229 - 239.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Lijnen
Angiotensin II-Induced Proliferation of Neonatal and Adult Rat Cardiac Fibroblasts
Hypertension, June 1, 2008; 51(6): e50 - e50.
[Full Text] [PDF]